Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Celldex Therapeutics is a biopharmaceutical company focused on developing antibody-based therapies targeting mast cell-driven diseases such as chronic urticaria, eosinophilic esophagitis, prurigo nodularis, and atopic dermatitis. Its portfolio includes monoclonal and bispecific antibodies designed to modulate immune pathways, with a focus on unmet medical needs. The company emphasizes research, clinical development, and strategic partnerships to advance innovative treatments for inflammatory and allergic conditions.
This description was generated via AI from an annual report. Updated about 1 year ago.